These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12669155)

  • 21. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of bacteria in the development of kidney stones.
    Kramer G; Klingler HC; Steiner GE
    Curr Opin Urol; 2000 Jan; 10(1):35-8. PubMed ID: 10650513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system.
    Koutsoukos PG; Lam-Erwin CY; Nancollas GH
    Invest Urol; 1980 Sep; 18(2):178-84. PubMed ID: 7410035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of nanobacteria on cell damage and crystal retention in renal tubular epithelial cells].
    Yu CF; Huang XB; Chen L; Xu QQ; Hu WG; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):436-42. PubMed ID: 20721259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population.
    Khullar M; Sharma SK; Singh SK; Bajwa P; Shiekh FA; Relan V; Sharma M
    Urol Res; 2004 Jun; 32(3):190-5. PubMed ID: 15205851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium phosphate/calcium oxalate crystal association in urinary stones: implications for heterogeneous nucleation of calcium oxalate.
    Khan SR
    J Urol; 1997 Jan; 157(1):376-83. PubMed ID: 8976301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequency and wide range of human kidney papillary crystalline plugs.
    Huguet L; Le Dudal M; Livrozet M; Bazin D; Frochot V; Perez J; Haymann JP; Brocheriou I; Daudon M; Letavernier E
    Urolithiasis; 2018 Aug; 46(4):333-341. PubMed ID: 29234857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental technique simulating oxalocalcic renal stone generation.
    Söhnel O; Grases F; March JG
    Urol Res; 1993 Mar; 21(2):95-9. PubMed ID: 8503154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
    Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
    Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cultivation and morphology of nanobacteria in sera of patients with kidney calculi].
    Chen L; Huang XB; Xu QQ; Li JX; Jia XJ; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):443-6. PubMed ID: 20721260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An understanding of renal stone development in a mixed oxalate-phosphate system.
    Guan X; Wang L; Dosen A; Tang R; Giese RF; Giocondi JL; Orme CA; Hoyer JR; Nancollas GH
    Langmuir; 2008 Jul; 24(14):7058-60. PubMed ID: 18557638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hypothesis for anti-nanobacteria effects of gallium with observations from treating kidney disease.
    Eby GA
    Med Hypotheses; 2008 Oct; 71(4):584-90. PubMed ID: 18579317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Biofilm Producer Nanobacteria Isolated from Kidney Stones of Some Egyptian Patients.
    Fayez Hassan N; Khaled Ibrahim M; Yousef El Tablawy S; Abd Allah Farrag H
    Pak J Biol Sci; 2021 Jan; 24(9):953-970. PubMed ID: 34585548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the pathogenetic role of physical exercise in renal stone formation.
    Sakhaee K; Nigam S; Snell P; Hsu MC; Pak CY
    J Clin Endocrinol Metab; 1987 Nov; 65(5):974-9. PubMed ID: 3667890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.